Therachon, a French achondroplasia drug developer, has raised $35m in a series-A from OrbiMed and New Enterprise Associates, as well as existing backers Inserm Transfert Initiative (ITI) and Versant Ventures.
Second vehicle will be larger than its predecessor, which closed on €843m in March 2010
Dieter von Holtzbrinck Ventures (DvH Ventures) has announced the launch of its first Digital Health fund, which has held a first close on €60m.
Sale ends a three-year holding period for Astorg, which acquired a 75% stake in the company from Xenon PE
Acquisition of Germany-based x-ray equipment and software was backed by senior debt from ApoBank